Short answer: Medical-grade PCB builds require full lot traceability from raw material to finished board. The backup board is supplied with a revision-controlled datasheet, per-lot COA, batch-traceability statement and material declaration under ISO 13485 and FDA 21 CFR 820, supporting FDA UDI and EU MDR 2017/745 requirements.
Number: Class II and III medical devices now expect component-level UDI and lot-level traceability; FDA 21 CFR Part 820 governs the quality system, 21 CFR Part 11 governs electronic records, and EU MDR 2017/745 Annex II requires lot-level process documentation retained for the product lifetime plus 10 years (AtlasPCB, HilPCB).
Boundary: The consumable evidence package supports but does not by itself certify the device. YUESHAN supplies the material documentation; final device classification and IEC 60601 validation sit with the legal manufacturer. See the medical drilling hub and the backup board definition.
Medical device PCBs carry a unique burden: patient safety. A failure in a medical PCB can directly harm or kill a patient, so regulators demand the highest quality standards and complete traceability across the product lifecycle — and that traceability reaches every consumable in the stack, including the backup board.
The documentation package
For a medical program, the consumable is qualified like any flight-critical item. The evidence package consists of:
| Document | What it proves | What invalidates it |
|---|---|---|
| Revision-controlled datasheet | the grade specified values, with revision and date | any change to a value without a revision |
| Per-lot COA | the delivered lot was measured against those values | delivery without a lot-matched COA |
| Batch-traceability statement | run, raw-material batch and date behind each lot | a break in the chain |
| Material declaration | substance content against RoHS and REACH | a formulation change |
Standards the program expects
| Standard | Scope |
|---|---|
| ISO 13485:2016 | Medical device quality-management system |
| FDA 21 CFR 820 / 830 / 11 | QSR, UDI, electronic records |
| EU MDR 2017/745 | Annex II technical file, Article 83 post-market surveillance |
| IEC 60601-1 (-2) | Medical electrical equipment safety and EMC |
| IPC-6012 Class 3 / DM | Medical addendum for rigid boards |
| UL 94 V-0 / ISO 10993 | Flammability and biocompatibility |
Why traceability matters
Regulators increasingly expect a fabricator to identify the specific PCB lot used in any Class III device within 24 hours of a recall, and to retain records for the product lifetime plus 10 years. YUESHAN supports this with full lot traceability, a sealed UV-melamine or HDF grade, ISO 9001 manufacture, REACH/RoHS declarations and grade locking so the qualified set never drifts. Final device classification and IEC 60601 validation remain with the legal manufacturer. See the medical drilling hub and the backup board definition.
